LC3-associated phagocytosis initiated by integrin ITGAM-ITGB2/Mac-1 enhances immunity to Listeria monocytogenes

Autophagy. 2018;14(8):1462-1464. doi: 10.1080/15548627.2018.1475816. Epub 2018 Jul 21.

Abstract

The macroautophagic/autophagic machinery cannot only target cell-endogenous components but also intracellular pathogenic bacteria such as Listeria monocytogenes. Listeria are targeted both by canonical autophagy and by a noncanonical form of autophagy referred to as LC3-associated phagocytosis (LAP). The molecular mechanisms involved and whether these processes contribute to anti-listerial immunity or rather provide Listeria with a replicative niche for persistent infection, however, remained unknown. Recently, using an in vivo mouse infection model, we have been able to demonstrate that Listeria in tissue macrophages are targeted exclusively by LAP. Furthermore, our data show that LAP is required for killing of Listeria by macrophages and thereby contributes to anti-listerial immunity of mice, whereas canonical autophagy is completely dispensable. Moreover, we have elucidated the molecular mechanisms that trigger LAP of Listeria and identified the integrin ITGAM-ITGB2/Mac-1/CR3/integrin αMß2 as the receptor that initiates LAP in response to Listeria infection.

Keywords: LC3-associated phagocytosis; Listeria monocytogenes; NAPDH oxidase Nox2; acid sphingomyelinase; lysosome; macrophages; noncanonical autophagy; reactive oxygen species; ß2 integrin Mac-1/CR3.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Autophagy*
  • CD18 Antigens
  • Listeria monocytogenes*
  • Macrophage-1 Antigen
  • Mice
  • Phagocytosis

Substances

  • CD18 Antigens
  • Macrophage-1 Antigen

Grants and funding

This work was supported by the Deutsche Forschungsgemeinschaft (DFG) [SFP 670].